K. Olugemo

Pharmacokinetics and safety of low-dose submicron indomethacin 20 and 40 mg compared with indomethacin 50 mg

C. Young, D. Solorio, K. Olugemo, 2015, Postgraduate medicine.

Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.

P. Desjardins, C. Young, D. Solorio, 2015, Clinical therapeutics.

Conducting CNS trials during a public health emergency – Lessons learned from the COVID-19 pandemic: A joint ISCTM/ECNP working group consensus paper

G. Dawson, J. Verster, D. Bugarski-Kirola, 2023, Neuroscience Applied.

ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable

M. Maurer, A. Dispenzieri, N. Fine, 2021, Orphanet Journal of Rare Diseases.

Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update

M. Benson, P. Dyck, M. Gertz, 2022, Journal of Neurology.